Proton pump inhibitors in children: A review

F. Marchetti, T. Gerarduzzi, A. Ventura

Research output: Contribution to journalArticle

Abstract

Proton pump inhibitors are often used to treat disorders associated with gastric hypersecretion in children, despite the lack of pediatric formulations. They are highly effective in the treatment of ulcers, gastro-esophageal reflux disorders and hypersecretory diseases. They provide a high level of gastric acid inhibition with few adverse effects. The aim of this article is to review the available studies concerning the use of proton pump inhibitors in pediatric populations and to point out: indications for use in children, optimal dosage, risk of adverse effects and consequences of the mechanism of action, and drug interactions. We performed a Medline and Embase search of publications printed from January 1980 to December 2002 concerning the use of proton pump inhibitors in children. We consider the available randomised controlled trials and several other uncontrolled studies conducted in the pediatric population, including all available information concerning the pediatric use of proton pump inhibitors. In children as well as in adults, there are clinical conditions (i.e., severe esophagitis or eradication of Helicobacter pylorii) in which proton pump inhibitors offer clear advantages over histamine-2 receptor antagonists. The relatively common use of acid inhibitors (proton pump inhibitors and histamine-2 receptor antagonists) in uncomplicated gastro-esophageal reflux disorders or in the prevention of non-steroidal anti-inflammatory drugs/steroid gastropathy is often unsubstantiated and should be limited to very specific situations. Multicentre randomised controlled studies are needed to better define the efficacy profile, the optimal dosage with respect to the different indications and the safety profile for chronic therapy of proton pump inhibitors in children.

Original languageEnglish
Pages (from-to)738-746
Number of pages9
JournalDigestive and Liver Disease
Volume35
Issue number10
DOIs
Publication statusPublished - Oct 2003

Fingerprint

Proton Pump Inhibitors
Pediatrics
Histamine Receptors
Gastroesophageal Reflux
Helicobacter
Esophagitis
Gastric Acid
Drug Interactions
Population
Ulcer
Publications
Stomach
Anti-Inflammatory Agents
Randomized Controlled Trials
Steroids
Safety
Acids
Therapeutics
Pharmaceutical Preparations

Keywords

  • Esophagitis
  • Gastro-esophageal reflux disorders
  • Helicobacter pylori eradication
  • Pharmacological properties
  • Proton pump inhibitors

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Proton pump inhibitors in children : A review. / Marchetti, F.; Gerarduzzi, T.; Ventura, A.

In: Digestive and Liver Disease, Vol. 35, No. 10, 10.2003, p. 738-746.

Research output: Contribution to journalArticle

Marchetti, F, Gerarduzzi, T & Ventura, A 2003, 'Proton pump inhibitors in children: A review', Digestive and Liver Disease, vol. 35, no. 10, pp. 738-746. https://doi.org/10.1016/S1590-8658(03)00420-1
Marchetti, F. ; Gerarduzzi, T. ; Ventura, A. / Proton pump inhibitors in children : A review. In: Digestive and Liver Disease. 2003 ; Vol. 35, No. 10. pp. 738-746.
@article{3ecaebc804284727961b82729fc5c2a1,
title = "Proton pump inhibitors in children: A review",
abstract = "Proton pump inhibitors are often used to treat disorders associated with gastric hypersecretion in children, despite the lack of pediatric formulations. They are highly effective in the treatment of ulcers, gastro-esophageal reflux disorders and hypersecretory diseases. They provide a high level of gastric acid inhibition with few adverse effects. The aim of this article is to review the available studies concerning the use of proton pump inhibitors in pediatric populations and to point out: indications for use in children, optimal dosage, risk of adverse effects and consequences of the mechanism of action, and drug interactions. We performed a Medline and Embase search of publications printed from January 1980 to December 2002 concerning the use of proton pump inhibitors in children. We consider the available randomised controlled trials and several other uncontrolled studies conducted in the pediatric population, including all available information concerning the pediatric use of proton pump inhibitors. In children as well as in adults, there are clinical conditions (i.e., severe esophagitis or eradication of Helicobacter pylorii) in which proton pump inhibitors offer clear advantages over histamine-2 receptor antagonists. The relatively common use of acid inhibitors (proton pump inhibitors and histamine-2 receptor antagonists) in uncomplicated gastro-esophageal reflux disorders or in the prevention of non-steroidal anti-inflammatory drugs/steroid gastropathy is often unsubstantiated and should be limited to very specific situations. Multicentre randomised controlled studies are needed to better define the efficacy profile, the optimal dosage with respect to the different indications and the safety profile for chronic therapy of proton pump inhibitors in children.",
keywords = "Esophagitis, Gastro-esophageal reflux disorders, Helicobacter pylori eradication, Pharmacological properties, Proton pump inhibitors",
author = "F. Marchetti and T. Gerarduzzi and A. Ventura",
year = "2003",
month = "10",
doi = "10.1016/S1590-8658(03)00420-1",
language = "English",
volume = "35",
pages = "738--746",
journal = "Digestive and Liver Disease",
issn = "1590-8658",
publisher = "Elsevier B.V.",
number = "10",

}

TY - JOUR

T1 - Proton pump inhibitors in children

T2 - A review

AU - Marchetti, F.

AU - Gerarduzzi, T.

AU - Ventura, A.

PY - 2003/10

Y1 - 2003/10

N2 - Proton pump inhibitors are often used to treat disorders associated with gastric hypersecretion in children, despite the lack of pediatric formulations. They are highly effective in the treatment of ulcers, gastro-esophageal reflux disorders and hypersecretory diseases. They provide a high level of gastric acid inhibition with few adverse effects. The aim of this article is to review the available studies concerning the use of proton pump inhibitors in pediatric populations and to point out: indications for use in children, optimal dosage, risk of adverse effects and consequences of the mechanism of action, and drug interactions. We performed a Medline and Embase search of publications printed from January 1980 to December 2002 concerning the use of proton pump inhibitors in children. We consider the available randomised controlled trials and several other uncontrolled studies conducted in the pediatric population, including all available information concerning the pediatric use of proton pump inhibitors. In children as well as in adults, there are clinical conditions (i.e., severe esophagitis or eradication of Helicobacter pylorii) in which proton pump inhibitors offer clear advantages over histamine-2 receptor antagonists. The relatively common use of acid inhibitors (proton pump inhibitors and histamine-2 receptor antagonists) in uncomplicated gastro-esophageal reflux disorders or in the prevention of non-steroidal anti-inflammatory drugs/steroid gastropathy is often unsubstantiated and should be limited to very specific situations. Multicentre randomised controlled studies are needed to better define the efficacy profile, the optimal dosage with respect to the different indications and the safety profile for chronic therapy of proton pump inhibitors in children.

AB - Proton pump inhibitors are often used to treat disorders associated with gastric hypersecretion in children, despite the lack of pediatric formulations. They are highly effective in the treatment of ulcers, gastro-esophageal reflux disorders and hypersecretory diseases. They provide a high level of gastric acid inhibition with few adverse effects. The aim of this article is to review the available studies concerning the use of proton pump inhibitors in pediatric populations and to point out: indications for use in children, optimal dosage, risk of adverse effects and consequences of the mechanism of action, and drug interactions. We performed a Medline and Embase search of publications printed from January 1980 to December 2002 concerning the use of proton pump inhibitors in children. We consider the available randomised controlled trials and several other uncontrolled studies conducted in the pediatric population, including all available information concerning the pediatric use of proton pump inhibitors. In children as well as in adults, there are clinical conditions (i.e., severe esophagitis or eradication of Helicobacter pylorii) in which proton pump inhibitors offer clear advantages over histamine-2 receptor antagonists. The relatively common use of acid inhibitors (proton pump inhibitors and histamine-2 receptor antagonists) in uncomplicated gastro-esophageal reflux disorders or in the prevention of non-steroidal anti-inflammatory drugs/steroid gastropathy is often unsubstantiated and should be limited to very specific situations. Multicentre randomised controlled studies are needed to better define the efficacy profile, the optimal dosage with respect to the different indications and the safety profile for chronic therapy of proton pump inhibitors in children.

KW - Esophagitis

KW - Gastro-esophageal reflux disorders

KW - Helicobacter pylori eradication

KW - Pharmacological properties

KW - Proton pump inhibitors

UR - http://www.scopus.com/inward/record.url?scp=9644294965&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9644294965&partnerID=8YFLogxK

U2 - 10.1016/S1590-8658(03)00420-1

DO - 10.1016/S1590-8658(03)00420-1

M3 - Article

C2 - 14620626

AN - SCOPUS:9644294965

VL - 35

SP - 738

EP - 746

JO - Digestive and Liver Disease

JF - Digestive and Liver Disease

SN - 1590-8658

IS - 10

ER -